<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>DKA Management Approach</title>
<style>
  body { font-family: Arial, sans-serif; line-height: 1.6; margin: 20px; }
  h1, h2, h3 { color: #004d66; }
  ul { margin-left: 20px; }
  li { margin-bottom: 5px; }
  .note { color: #555; font-style: italic; margin-top: 5px; }
</style>
</head>
<body>

<h1>Diabetic Ketoacidosis (DKA) – Management Approach</h1>

<h2>1. Initial Steps</h2>
<ul>
  <li>Perform <strong>ABCDE assessment</strong>.</li>
  <li>Obtain urgent diagnostics:
    <ul>
      <li>Point-of-care (POC) glucose</li>
      <li>Basic metabolic panel (BMP)</li>
      <li>Blood gas analysis</li>
    </ul>
  </li>
  <li>Assess volume status.</li>
</ul>

<h2>2. Principal Interventions</h2>
<ul>
  <li><strong>Fluid resuscitation:</strong> Start with 0.9% NaCl or lactated Ringer’s solution.</li>
  <li><strong>Potassium repletion:</strong> Begin if baseline K⁺ ≤ 5.0 mEq/L. Maintain K⁺ between 4–5 mEq/L.</li>
  <li><strong>Insulin therapy:</strong> Initiate short-acting IV insulin when K⁺ > 3.5 mEq/L.</li>
  <li><strong>Sodium bicarbonate:</strong> Consider only if severe refractory metabolic acidosis (pH &lt; 7.0).</li>
  <li><strong>Identify and treat precipitating causes</strong> (e.g., sepsis, myocardial infarction).</li>
  <li>Avoid rapid correction of serum sodium and osmolality to prevent cerebral edema.</li>
  <li>Consult endocrinology and consider ICU admission.</li>
</ul>

<h2>3. Noninsulin Diabetes Medications</h2>
<ul>
  <li>Avoid noninsulin agents in patients with type 1 diabetes mellitus.</li>
  <li>Stop SGLT2 inhibitors.</li>
  <li>For type 2 diabetes, other agents may be considered with endocrinology input.</li>
</ul>

<h2>4. Monitoring</h2>
<ul>
  <li>Check vital signs, mental status, and hydration hourly.</li>
  <li>POC glucose every 1–2 hours until resolution of hyperglycemia.</li>
  <li>Blood gas and BMP (including electrolytes) every 2–4 hours.</li>
  <li>For DKA: measure serum β-hydroxybutyrate every 4 hours.</li>
  <li>For HHS: monitor serum osmolality every 2–4 hours.</li>
  <li>Monitor for signs of cerebral edema (headache, mental status changes, seizures).</li>
</ul>

<h2>5. Disposition</h2>
<ul>
  <li><strong>Admission:</strong> Indicated for all patients with HHS and most with DKA.</li>
  <li><strong>ICU admission:</strong> If severe DKA/HHS, hemodynamic instability, or altered mental status.</li>
  <li><strong>Discharge criteria (mild DKA):</strong>
    <ul>
      <li>Acidosis resolved</li>
      <li>No serious precipitating cause</li>
      <li>Tolerates oral intake</li>
      <li>Stable on basal-bolus insulin regimen</li>
      <li>Reliable follow-up possible</li>
    </ul>
  </li>
</ul>

<h3>Key Notes</h3>
<p class="note">Maintain serum potassium between 4–5 mEq/L.</p>
<p class="note">Avoid rapid correction of hyponatremia to prevent osmotic demyelination syndrome.</p>
<p class="note">Rapid fall in serum osmolality can lead to cerebral edema.</p>

<h3>Special Consideration</h3>
<p>Pregnant patients with DKA require joint management by an endocrinologist and obstetrician due to high maternal-fetal risk.</p>

<hr>

<p>For detailed guidance, see the AMBOSS resource:</p>
<ul>
  <li><a href="https://www.amboss.com/us/knowledge/hyperglycemic-crises?utm_medium=chatgpt-plugin&utm_source=chatgpt" target="_blank">Hyperglycemic Crises (DKA &amp; HHS)</a></li>
</ul>

</body>
</html>
